Novel theranostic options for high-risk non-muscle invasive bladder cancer are urgently needed. This requires a thorough evaluation of experimental approaches in animal models best possibly reflecting human disease before entering clinical studies. | An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice Influence of mouse strain tumor cell count dwell time and bladder pretreatment